US FDA announces emergency authorization for convalescent plasma to treat Covid

The US Food and Drug Administration on Sunday issued an emergency use authorization for convalescent plasma to treat Covid-19, saying the "known and potential benefits of the product outweigh the known and potential risks of the product." Pročitaj više